Stay updated on Expanded Access to Upadacitinib Clinical Trial
Sign up to get notified when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.

Latest updates to the Expanded Access to Upadacitinib Clinical Trial page
- CheckyesterdayChange DetectedUpdated the study record's revision from v3.5.3 to v3.5.4, reflecting an administrative update to the ClinicalTrials.gov entry.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page shows a new revision identifier (v3.5.3) replacing v3.5.2. This indicates a minor update to the page (likely formatting or backend fixes) without changing study details.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.5.2. This appears to be a maintenance/version update with no visible changes to study details or user-facing content.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision label v3.4.3 was added and the v3.4.2 revision label was removed.SummaryDifference0.1%

- Check94 days agoChange DetectedA new Revision: v3.4.2 has been added, and the previous Notice about a lapse in government funding (Revision: v3.4.1) has been removed. These updates are administrative and do not affect the core study information or accessibility of the expanded access program. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

Stay in the know with updates to Expanded Access to Upadacitinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access to Upadacitinib Clinical Trial page.